Serina Therapeutics, Inc. Quarterly Cost of Revenue in USD from Q1 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Serina Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2018 to Q4 2023.
  • Serina Therapeutics, Inc. Cost of Revenue for the quarter ending December 31, 2023 was $1K, unchanged year-over-year.
  • Serina Therapeutics, Inc. Cost of Revenue for the twelve months ending December 31, 2023 was $40K, a 208% increase year-over-year.
  • Serina Therapeutics, Inc. annual Cost of Revenue for 2023 was $40K, a 208% increase from 2022.
  • Serina Therapeutics, Inc. annual Cost of Revenue for 2022 was $13K, a 31.6% decline from 2021.
  • Serina Therapeutics, Inc. annual Cost of Revenue for 2021 was $19K, a 26.9% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $40K $1K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $40K $33K +$28K +560% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $12K $5K -$1K -16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $13K $1K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $13K $1K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $13K $5K +$3K +150% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $10K $6K -$7K -53.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $17K $1K -$2K -66.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $19K $1K -$4K -80% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $23K $2K -$15K -88.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $38K $13K +$10K +333% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $28K $3K +$2K +200% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $26K $5K -$74K -93.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $100K $17K -$32K -65.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $132K $3K -$50K -94.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $182K $1K -$62K -98.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $244K $79K -$101K -56.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $345K $49K +$53K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $292K $53K -$26K -32.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $318K $63K -$46K -42.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $364K $180K Oct 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
Q3 2018 -$4K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $79K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $109K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.